LGALS3 and inflammatory bowel disease: Thus, during IBD, upregulation of galectin-3 may contribute to enhanced synthesis of proinflammatory cytokines in dendritic cells and may also stimulate the activation of Th17 and Th2 cells, which are considered key pathogenic cells in CD and UC, respectively.